Eric Lefkofsky is has helped lead to the rise of the Tempus businesses and their data-enabling precision technology that allows precision medicine to help patients who are suffering from cancer or other similar conditions. Lefkofksky precision medicine is in growing demand as more than 40% of US adults facing some type of cancer diagnosis at some point and everyone knows someone who has fought a battle with cancer in their lifetime. The cancer institute says there were about 14.5 million people living with cancer in 2014. The figure is expected to rise to about 19 million by 2024, however, thanks to improvements in treatments prognosis for people with cancer is looking better than ever before as people like Lefkofsky pioneer medicine to help people win their battles with cancer.
Eric Lefkofsky is the co-founder and CEO of the Tempus company which uses the latest technology to build operating systems that help people fighting cancer. He is also the founder of Lightbank which is venture fund that invests money in disruptive technologies. Lefkofsky also invests in several other companies that help contribute technology to his Tempus company and help fight against the cancers that they are trying to cancet treatment and find cures for.
On the side, Eric Lefkofsky is a philanthropist and in 2006 he established his very on Lefkofsky Family Foundation which he started with his wife Liz to help advance high-impact initiatives in lower-income communities to help enhance the lives of the people living in those communities. In his spare time, Lefkofsky also serves as a Chairman of the Board of Trustees of the Steppenwolf Theatre Company and also does extensive work with the Chicago are children’s hospitals as well to learn more: http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life click here.
He also serves as an adjunct professor at the University of Chicago and is the author of his own book the “Accelerated Disruption” where he talks about his work he does to fight cancer and how to disrupt the pattern of it growing in the human body with the technology we have today.